Incyte is a global biopharmaceutical company focused on the discovery, development, and commercialization of new therapeutics. Driven by science and research, Incyte is committed to improving patients' lives by providing innovative solutions.

We have an experienced team with a track record of success, and we strive to develop superior therapeutics to meet high medical needs. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.

In addition to headquarters in Wilmington (Delaware, USA), and Morges (Switzerland), Incyte has operations in North America, Europe, and Asia.

For additional information on Incyte, please visit


For general inquiries and to contact Incyte Switzerland, please email

If you have had any adverse incidents, unusual situations or product complaints related to any of the products of Incyte, then please do not hesitate to contact Incyte Biosciences Europe Medical Information:

00800 00027423*
View country-specific contact information here.

*This number is active in the following countries: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PL, PT, RU, SE, SK and SI. Please note, per country requirements, you may be required to dial (+), (0), or (00) before the free phone number.